Search tips
Search criteria 


Logo of bmcphBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Public Health
BMC Public Health. 2012; 12: 415.
Published online Jun 7, 2012. doi:  10.1186/1471-2458-12-415
PMCID: PMC3438100
Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009
Lorenzo Pezzoli,corresponding author1 Ishata Conteh,2 Wogba Kamara,3 Marta Gacic-Dobo,4 Olivier Ronveaux,5 William A Perea,6 and Rosamund F Lewis6
1Consultant for the World Health Organization, Geneva, Switzerland
2Immunization and Vaccine Development, World Health Organization, Freetown, Sierra Leone
3Statistics Sierra Leone, Freetown, Sierra Leone
4Immunization Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
5Immunization and Vaccine Development, World Health Organization, Ouagadougou, Burkina Faso
6Epidemic Readiness and Intervention, World Health Organization, Geneva, Switzerland
corresponding authorCorresponding author.
Lorenzo Pezzoli: lorenzo.pezz/at/; Ishata Conteh: contehi/at/; Wogba Kamara: kamarawogba/at/; Marta Gacic-Dobo: gacicdobom/at/; Olivier Ronveaux: ronveauxo/at/; William A Perea: pereaw/at/; Rosamund F Lewis: rosamund_lewis/at/
Received February 23, 2012; Accepted June 7, 2012.
In November 2009, Sierra Leone conducted a preventive yellow fever (YF) vaccination campaign targeting individuals aged nine months and older in six health districts. The campaign was integrated with a measles follow-up campaign throughout the country targeting children aged 9–59 months. For both campaigns, the operational objective was to reach 95% of the target population. During the campaign, we used clustered lot quality assurance sampling (C-LQAS) to identify areas of low coverage to recommend timely mop-up actions.
We divided the country in 20 non-overlapping lots. Twelve lots were targeted by both vaccinations, while eight only by measles. In each lot, five clusters of ten eligible individuals were selected for each vaccine. The upper threshold (UT) was set at 90% and the lower threshold (LT) at 75%. A lot was rejected for low vaccination coverage if more than 7 unvaccinated individuals (not presenting vaccination card) were found. After the campaign, we plotted the C-LQAS results against the post-campaign coverage estimations to assess if early interventions were successful enough to increase coverage in the lots that were at the level of rejection before the end of the campaign.
During the last two days of campaign, based on card-confirmed vaccination status, five lots out of 20 (25.0%) failed for having low measles vaccination coverage and three lots out of 12 (25.0%) for low YF coverage. In one district, estimated post-campaign vaccination coverage for both vaccines was still not significantly above the minimum acceptable level (LT = 75%) even after vaccination mop-up activities.
C-LQAS during the vaccination campaign was informative to identify areas requiring mop-up activities to reach the coverage target prior to leaving the region. The only district where mop-up activities seemed to be unsuccessful might have had logistical difficulties that should be further investigated and resolved.
Keywords: Clustered lot quality assurance sampling (C-LQAS), Measles vaccine, Yellow fever vaccine, Vaccination coverage, Monitoring, Africa, Sierra Leone
Articles from BMC Public Health are provided here courtesy of
BioMed Central